Catalyst Pharmaceuticals Inc

General ticker "CPRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.6B

Catalyst Pharmaceuticals Inc follows the US Stock Market performance with the rate: 61.5%.

Estimated limits based on current volatility of 1.7%: low 21.12$, high 21.84$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [14.21$, 25.06$]
  • 2024-12-30 to 2025-12-30 estimated range: [16.87$, 28.99$]

Financial Metrics affecting the CPRX estimates:

  • Positive: 0.10 < Non-GAAP EPS, $ of 0.88
  • Positive: Operating profit margin, % of 21.80 > 19.51
  • Positive: Return on assets ratio (scaled to [-100,100]) of 13.19 > 7.10
  • Positive: -3.48 < Investing cash flow per share, $ of -2.76

Similar symbols

Short-term CPRX quotes

Long-term CPRX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $140.83MM $214.20MM $398.20MM
Operating Expenses $88.45MM $112.36MM $311.39MM
Operating Income $52.38MM $101.84MM $86.81MM
Non-Operating Income $0.28MM $2.88MM $7.70MM
R&D Expense $16.94MM $19.79MM $93.15MM
Income(Loss) $52.67MM $104.72MM $94.51MM
Taxes $13.19MM $21.64MM $23.10MM
Profit(Loss) $39.48MM $83.08MM $71.41MM
Stockholders Equity $206.83MM $300.42MM $387.88MM
Inventory $7.87MM $6.80MM $15.64MM
Assets $237.79MM $375.63MM $470.11MM
Operating Cash Flow $60.37MM $116.05MM $143.60MM
Capital expenditure $1.02MM $0.03MM $198.52MM
Investing Cash Flow $-11.02MM $9.21MM $-293.50MM
Financing Cash Flow $-8.14MM $1.69MM $-10.86MM
Earnings Per Share* $0.38 $0.80 $0.67

* EPS are Split Adjusted, recent splits may be reflected with a delay.